J4 ›› 2010, Vol. 36 ›› Issue (1): 63-66.

• 基础研究 • 上一篇    下一篇

131I标记抗c-erbB-2单克隆抗体对卵巢癌动物模型的生长抑制作用

 许天敏1, 崔满华1, 谷丽萍1, 崔松花1, 苏曼曼2, 王文加2, 王丁丁3   

  1. (1.吉林大学第二医院妇产科| 吉林 长春 130041;2.吉林大学药学院医学生物工程教研室|
    吉林 长春 130021;3.广东药学院生命科学与生物制药学院生物技术教研室|广东 广州 510240)
  • 收稿日期:2009-02-03 出版日期:2010-01-28 发布日期:2010-02-28
  • 通讯作者: 崔满华 E-mail:(Tel:0431-88796212,E-mail:cuimanhua@126.com)
  • 作者简介:许天敏(1974-)|女|吉林省延吉市人|主治医师|医学博士|主要从事妇科肿瘤的研究。
  • 基金资助:

    吉林省科技厅科研基金资助课题(200705203,20080134)

Inhibitory effect of anti-c-erbB-2 monoclonal antibody labeled with 131I on growth of ovarian cancer in mude mice

HU Tian-Min1, CUI Man-Hua1, GU Li-Ping1, CUI Song-Hua1, SU Man-Man2, WANG Wen-Jia2, WANG Ding-Ding3   

  1. (1.Department of Obstetrics and Gynecology,Second Hospital,Jilin University,Changchun 130041,China;2. Department of Bioengineering,School of Pharmacy, Jilin University,Changchun 130021,China;3. Department of Biotechnology,School of Life Science and Biopharmacology,Guangdong PharmaceuticalUniversity,Guangzhou 510240,China)
  • Received:2009-02-03 Online:2010-01-28 Published:2010-02-28

摘要:

目的:用131I标记抗c-erbB-2单克隆抗体,探讨其对荷人卵巢癌裸鼠的生长抑制作用。方法:将抗c-erbB-2单克隆抗体与131I偶联,制成免疫靶向药物,将已接种卵巢癌SKOV3细胞且肿瘤直径已达1.0 cm的裸鼠分为131I标记抗c-erbB-2单克隆抗体3.7 MBq低剂量组和11.1 MBq高剂量组,以131I标记的mIgG(非治疗性抗体)为对照组,对三组荷人卵巢癌裸鼠模型分别进行肿瘤局部注射,于用药当日后6周内每周测量肿瘤体积、质量,计算抑瘤率,并与对照组进行比较。结果:131I标记抗c-erbB-2单克隆抗体3.7 MBq低剂量组和11.1MBq高剂量组与对照组比较肿瘤体积减小(P<0.05)、肿瘤质量减轻(P<0.05)、抑瘤率增高(P<0.05),同时131I标记抗c-erbB-2单克隆抗体11.1MBq高剂量组肿瘤体积和肿瘤质量低于3.7 MBq低剂量组(P<0.05)、抑瘤率高于3.7 MBq低剂量组(P<0.05)。结论:131I标记抗c-erbB-2单克隆抗体对荷人卵巢癌裸鼠肿瘤的生长有明显的抑制作用,且以131I标记抗c-erbB-2单克隆抗体11.1 MBq剂量作用强于3.7 MBq剂量。

关键词: 卵巢肿瘤;c-erbB-2;抗体, 单克隆;131I;放射免疫疗法

Abstract:

Abstract:Objective To label anti- c-erbB-2 monoclonal antibody  with 131I,and investigate its inhibitory effect on the growth of ovarian cancer in mude mice.Methods Anti-c-erbB2 monoclonal antibody was combined with 131I to produce radioimmunological targeting drug.The nude mice which had been inoculated subcutaneously with ovarian cancer SKOV3 cells and the diameter of tumor mass was about 1.0 cm were randomly divided into 3 groups:G1,G2 and control groups.The mice in G1 and G2 groups were treated with 11.1 MBq and 3.7 MBq anti-c-erbB2 monoclonal antibody labeled with 131Irespectively.The mice in control group was treated with mIgG labeled with 131I.The size and weight of tumor were determined once every week during 6 weeks after administration.Results Compared with  control group, the  size and weight of tumor in G1 and G2 groups were significantly decreased,and the inhibitory rate was increased(P<0.05). The size and weight of tumor in G1 group were lower than those in G2 group(P<0.05),and the inhibirory rate in G1 group  was higher than that in G2 group(P<0.05) .Conclusion Anti-c-erbB-2 monoclonal antibody labeled with radionuclide 131Icould inhibit the growth of ovarian cancer in nude mice and the effect of 11.1 MBq c-erbB-2 monoclonal antibody labeled with 131Iis better than 3.7 MBq  131I-c-erbB-2.

Key words: ovarian neoplasms;c-erbB-2;antibodies monoelonal;131I; , radioimmunotherapy

中图分类号: 

  • R815